NCT02927626 Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma Status COMPLETED Phase EARLY_PHASE1
NCT02908165 Randomized Phase II Trial of Chemoembolization and Sorafenib Status WITHDRAWN Phase PHASE2
NCT02905188 Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR) Status COMPLETED Phase PHASE1
NCT02886897 A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT02881554 Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery Status TERMINATED Phase NA
NCT02868255 Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT02867592 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02867280 Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection Status TERMINATED Phase PHASE3
NCT02859753 Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation Status COMPLETED Phase NA
NCT02856126 HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC Status COMPLETED Phase PHASE3
NCT02854839 A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02854241 Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance Status UNKNOWN Phase NA
NCT02851784 Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT02839954 CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT02834780 Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02833298 Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening Status COMPLETED Phase NA